Biohaven Ltd. (BHVN)
NYSE: BHVN · Real-Time Price · USD
37.59
+1.74 (4.85%)
At close: Jan 17, 2025, 4:00 PM
37.30
-0.29 (-0.77%)
Pre-market: Jan 21, 2025, 4:14 AM EST
Biohaven Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Selling, General & Admin | 85.68 | 62.77 | 130.86 | 37.41 | 16.05 |
| Research & Development | 763.21 | 373.28 | 333.33 | 181.49 | 98.46 |
| Operating Expenses | 848.89 | 436.05 | 464.19 | 218.9 | 114.51 |
| Operating Income | -848.89 | -436.05 | -464.19 | -218.9 | -114.51 |
| Earnings From Equity Investments | - | - | - | 5.26 | -4.16 |
| Other Non Operating Income (Expenses) | 23.25 | 8.81 | 4.88 | 1.21 | - |
| EBT Excluding Unusual Items | -825.65 | -427.24 | -459.3 | -212.43 | -118.67 |
| Gain (Loss) on Sale of Investments | 20.79 | 17.69 | -6.79 | - | - |
| Other Unusual Items | - | - | -103.75 | - | - |
| Pretax Income | -804.86 | -409.55 | -569.84 | -212.43 | -118.67 |
| Income Tax Expense | -0.53 | -1.38 | 0.44 | 1.37 | - |
| Net Income | -804.34 | -408.17 | -570.28 | -213.8 | -118.67 |
| Net Income to Common | -804.34 | -408.17 | -570.28 | -213.8 | -118.67 |
| Shares Outstanding (Basic) | 86 | 71 | 45 | 39 | 39 |
| Shares Outstanding (Diluted) | 86 | 71 | 45 | 39 | 39 |
| Shares Change (YoY) | 29.45% | 59.14% | 13.63% | - | - |
| EPS (Basic) | -9.36 | -5.73 | -12.75 | -5.43 | -3.01 |
| EPS (Diluted) | -9.36 | -5.73 | -12.75 | -5.43 | -3.01 |
| Free Cash Flow | -531.06 | -334.77 | -303.76 | -146.78 | -78.65 |
| Free Cash Flow Per Share | -6.18 | -4.70 | -6.79 | -3.73 | -2.00 |
| EBITDA | -841.6 | -429.14 | -462.8 | -217.51 | -114.43 |
| D&A For EBITDA | 7.29 | 6.91 | 1.39 | 1.39 | 0.07 |
| EBIT | -848.89 | -436.05 | -464.19 | -218.9 | -114.51 |
Source: S&P Capital IQ. Standard template.
Financial Sources.